HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination.

Abstract
The IgG-, IgM- and IgA- anti-pneumococcal antibody response to pneumococcal vaccination in 29 splenectomized adults and adolescents with hereditary spherocytosis or previous traumatic splenic rupture was determined by an enzyme-linked immunosorbent assay. It was not significantly different from that of 12 healthy controls except for a lower IgM class antibody increase in the splenectomized against one of four antigens studied. The antibody response was predominantly of IgG class, but significant increases in IgM and IgA class antibodies against all four antigens (polysaccharide types 2, 6A, 12F and 14) studied were observed. In 1/29 splenectomized and 2/12 healthy individuals (7%) the IgG antibody class did not predominate. In 36 adults and adolescents splenectomized due to traumatic rupture or during surgery for gastric ulcer, 77% of the peak geometric mean total antibody concentration four weeks after vaccination was still present after 21 months (16-26 months).
AuthorsF K Pedersen, J L Nielsen, J Ellegaard
JournalActa pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology (Acta Pathol Microbiol Immunol Scand C) Vol. 91 Issue 4 Pg. 245-9 (Aug 1983) ISSN: 0108-0202 [Print] Denmark
PMID6637480 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Immunoglobulins
Topics
  • Adolescent
  • Adult
  • Antibodies, Bacterial (analysis)
  • Bacterial Vaccines (immunology)
  • Child
  • Female
  • Humans
  • Immunoglobulins (analysis)
  • Male
  • Middle Aged
  • Postoperative Period
  • Spleen (immunology)
  • Splenectomy
  • Streptococcus pneumoniae (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: